{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T09:05:42Z","timestamp":1782291942820,"version":"3.54.5"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1012444","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000}}],"reference-count":80,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["161L0213"],"award-info":[{"award-number":["161L0213"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Training Program for Academic and Technical Leaders of Major Disciplines in Jiangxi Province-Leading Talents Project","award":["20213BCJ22011"],"award-info":[{"award-number":["20213BCJ22011"]}]},{"name":"Key Projects of Natural Science Foundation of Jiangxi Province","award":["20212ACB206032"],"award-info":[{"award-number":["20212ACB206032"]}]},{"name":"Discipline Leader Training Plan of Pudong New Area Health Commission","award":["PWRd2020-11"],"award-info":[{"award-number":["PWRd2020-11"]}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>Multiple myeloma (MM) is a hematological disease exhibiting aberrant clonal expansion of cancerous plasma cells in the bone marrow. The effects of treatments for MM vary between patients, highlighting the importance of developing prognostic models for informed therapeutic decision-making. Most previous models were constructed at the gene level, ignoring the fact that the dysfunction of the pathway is closely associated with disease development and progression. The present study considered two strategies that construct predictive models by taking pathway information into consideration: pathway score method and group lasso using pathway information. The former simply converted gene expression to sample-wise pathway scores for model fitting. We considered three methods for pathway score calculation (ssGSEA, GSVA, and z-scores) and 14 data sources providing pathway information. We implemented these methods in microarray data for MM (GSE136324) and obtained a candidate model with the best prediction performance in interval validation. The candidate model is further compared with the gene-based model and previously published models in two external data. We also investigated the effects of missing values on prediction. The results showed that group lasso incorporating Vax pathway information (Vax(grp)) was more competitive in prediction than the gene model in both internal and external validation. Immune information, including VAX pathways, seemed to be more predictive for MM. Vax(grp) also outperformed the previously published models. Moreover, the new model was more resistant to missing values, and the presence of missing values (&lt;5%) would not evidently deteriorate its prediction accuracy using our missing data imputation method. In a nutshell, pathway-based models (using group lasso) were competitive alternatives to gene-based models for MM. These models were documented in an R package (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/github.com\/ShuoStat\/MMMs\" xlink:type=\"simple\">https:\/\/github.com\/ShuoStat\/MMMs<\/jats:ext-link>), where a missing data imputation method was also integrated to facilitate future validation.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1012444","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T17:34:21Z","timestamp":1725989661000},"page":"e1012444","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Construct prognostic models of multiple myeloma with pathway information incorporated"],"prefix":"10.1371","volume":"20","author":[{"given":"Shuo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ShanJin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YuYang","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9211-0746","authenticated-orcid":true,"given":"Junyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"pcbi.1012444.ref001","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S0268-960X(10)70003-5","article-title":"Multiple myeloma: biology of the disease","volume":"24","author":"A Mahindra","year":"2010","journal-title":"Blood reviews"},{"issue":"12","key":"pcbi.1012444.ref002","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.ejrad.2013.08.036","article-title":"Diagnostic value of whole-body low-dose computed tomography (WBLDCT) in bone lesions detection in patients with multiple myeloma (MM)","volume":"82","author":"D Ippolito","year":"2013","journal-title":"European Journal of Radiology"},{"issue":"7","key":"pcbi.1012444.ref003","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/sj.leu.2404253","article-title":"Prognostic value of cyclin D2 mRNA expression in newly diagnosed multiple myeloma treated with high-dose chemotherapy and tandem autologous stem cell transplantations","volume":"20","author":"I Hanamura","year":"2006","journal-title":"Leukemia"},{"issue":"11","key":"pcbi.1012444.ref004","doi-asserted-by":"crossref","first-page":"e1003323","DOI":"10.1371\/journal.pmed.1003323","article-title":"Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials","volume":"17","author":"SA Danziger","year":"2020","journal-title":"PLoS medicine"},{"issue":"5","key":"pcbi.1012444.ref005","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ccr.2004.10.020","article-title":"Focus on multiple myeloma","volume":"6","author":"CS Mitsiades","year":"2004","journal-title":"Cancer cell"},{"issue":"8","key":"pcbi.1012444.ref006","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrclinonc.2011.63","article-title":"Treatment of multiple myeloma","volume":"8","author":"SV Rajkumar","year":"2011","journal-title":"Nature reviews Clinical oncology"},{"key":"pcbi.1012444.ref007","first-page":"101","volume-title":"Mayo Clinic Proceedings:","author":"SV Rajkumar"},{"issue":"3","key":"pcbi.1012444.ref008","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1039\/C6MB00757K","article-title":"Topologically inferring pathway activity for precise survival outcome prediction: breast cancer as a case","volume":"13","author":"W Liu","year":"2017","journal-title":"Molecular bioSystems"},{"issue":"12","key":"pcbi.1012444.ref009","doi-asserted-by":"crossref","first-page":"giz153","DOI":"10.1093\/gigascience\/giz153","article-title":"Prognostic model for multiple myeloma progression integrating gene expression and clinical features","volume":"8","author":"C Sun","year":"2019","journal-title":"Gigascience"},{"issue":"11","key":"pcbi.1012444.ref010","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1038\/leu.2014.140","article-title":"Gene expression profile alone is inadequate in predicting complete response in multiple myeloma.","volume":"28","author":"SB Amin","year":"2014","journal-title":"Leukemia"},{"issue":"4","key":"pcbi.1012444.ref011","first-page":"1837","article-title":"A comprehensive analysis of prognosis prediction models based on pathway-level, gene-level and clinical information for glioblastoma","volume":"42","author":"R Liang","year":"2018","journal-title":"International journal of molecular medicine"},{"issue":"1","key":"pcbi.1012444.ref012","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00277-001-0388-5","article-title":"Simple prognostic model for patients with multiple myeloma: a single-center study in Japan","volume":"81","author":"M Kaneko","year":"2002","journal-title":"Annals of hematology"},{"issue":"19","key":"pcbi.1012444.ref013","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1200\/JCO.18.00776","article-title":"Development and validation of a cytogenetic prognostic index predicting survival in multiple myeloma","volume":"37","author":"A Perrot","year":"2019","journal-title":"Journal of Clinical Oncology"},{"issue":"8","key":"pcbi.1012444.ref014","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nm1087","article-title":"Cancer genes and the pathways they control","volume":"10","author":"B Vogelstein","year":"2004","journal-title":"Nature medicine"},{"issue":"9","key":"pcbi.1012444.ref015","doi-asserted-by":"crossref","first-page":"e1003851","DOI":"10.1371\/journal.pcbi.1003851","article-title":"A novel model to combine clinical and pathway-based transcriptomic information for the prognosis prediction of breast cancer","volume":"10","author":"S Huang","year":"2014","journal-title":"PLoS computational biology"},{"issue":"1","key":"pcbi.1012444.ref016","first-page":"1","article-title":"Predictive modelling using pathway scores: robustness and significance of pathway collections","volume":"20","author":"MP Segura-Lepe","year":"2019","journal-title":"BMC bioinformatics"},{"issue":"11","key":"pcbi.1012444.ref017","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.3390\/biomedicines9111502","article-title":"Pathway-Based Personalized Analysis of Pan-Cancer Transcriptomic Data","volume":"9","author":"C Pian","year":"2021","journal-title":"Biomedicines"},{"issue":"9","key":"pcbi.1012444.ref018","doi-asserted-by":"crossref","first-page":"e1005125","DOI":"10.1371\/journal.pcbi.1005125","article-title":"Data-driven metabolic pathway compositions enhance cancer survival prediction","volume":"12","author":"N Auslander","year":"2016","journal-title":"PLoS computational biology"},{"issue":"7","key":"pcbi.1012444.ref019","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1038\/bcj.2016.64","article-title":"Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myeloma","volume":"6","author":"Y Jethava","year":"2016","journal-title":"Blood cancer journal"},{"issue":"21","key":"pcbi.1012444.ref020","first-page":"4168","article-title":"Superior results of Total Therapy 3 (2003\u201333) in gene expression profiling\u2013defined low-risk multiple myeloma confirmed in subsequent trial 2006\u201366 with VRD maintenance","volume":"115","author":"B Nair","year":"2010","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"pcbi.1012444.ref021","volume-title":"Total Therapies (TT) for Newly Diagnosed Patients with Multiple Myeloma (MM): Significant Benefit in High-Risk Disease with Cytogenetic Abnormalities (CA) over the Course of 17 Years","author":"F van Rhee","year":"2006"},{"issue":"8","key":"pcbi.1012444.ref022","first-page":"3177","article-title":"Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib","volume":"109","author":"G Mulligan","year":"2007","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"6","key":"pcbi.1012444.ref023","first-page":"2020","article-title":"The molecular classification of multiple myeloma","volume":"108","author":"F Zhan","year":"2006","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"4","key":"pcbi.1012444.ref024","first-page":"1692","article-title":"Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis","volume":"109","author":"F Zhan","year":"2007","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"1","key":"pcbi.1012444.ref025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"S H\u00e4nzelmann","year":"2013","journal-title":"BMC bioinformatics"},{"issue":"16","key":"pcbi.1012444.ref026","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1073\/pnas.1219651110","article-title":"Pathway-based personalized analysis of cancer","volume":"110","author":"Y Drier","year":"2013","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"7","key":"pcbi.1012444.ref027","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.molonc.2015.04.006","article-title":"Pathway-based personalized analysis of breast cancer expression data","volume":"9","author":"A Livshits","year":"2015","journal-title":"Molecular oncology"},{"issue":"1","key":"pcbi.1012444.ref028","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1534\/genetics.116.189191","article-title":"Pathway-structured predictive model for cancer survival prediction: a two-stage approach","volume":"205","author":"X Zhang","year":"2017","journal-title":"Genetics"},{"issue":"43","key":"pcbi.1012444.ref029","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"A Subramanian","year":"2005","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"7269","key":"pcbi.1012444.ref030","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08460","article-title":"Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1","volume":"462","author":"DA Barbie","year":"2009","journal-title":"Nature"},{"issue":"11","key":"pcbi.1012444.ref031","doi-asserted-by":"crossref","first-page":"e1000217","DOI":"10.1371\/journal.pcbi.1000217","article-title":"Inferring pathway activity toward precise disease classification","volume":"4","author":"E Lee","year":"2008","journal-title":"PLoS computational biology"},{"key":"pcbi.1012444.ref032","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-20192-9","volume-title":"Statistics for high-dimensional data: methods, theory and applications","author":"P B\u00fchlmann","year":"2011"},{"issue":"15","key":"pcbi.1012444.ref033","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1080\/00949655.2018.1491575","article-title":"A study on tuning parameter selection for the high-dimensional lasso","volume":"88","author":"D Homrighausen","year":"2018","journal-title":"Journal of Statistical Computation and Simulation"},{"issue":"12","key":"pcbi.1012444.ref034","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3.0","volume":"27","author":"A Liberzon","year":"2011","journal-title":"Bioinformatics"},{"issue":"18","key":"pcbi.1012444.ref035","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1001\/jama.1982.03320430047030","article-title":"Evaluating the yield of medical tests","volume":"247","author":"FE Harrell","year":"1982","journal-title":"Jama"},{"issue":"14","key":"pcbi.1012444.ref036","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/bioinformatics\/btm232","article-title":"Assessment of survival prediction models based on microarray data","volume":"23","author":"M Schumacher","year":"2007","journal-title":"Bioinformatics"},{"issue":"4","key":"pcbi.1012444.ref037","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1109\/TCBB.2012.31","article-title":"A Hybrid Approach to Survival Model Building Using Integration of Clinical and Molecular Information in Censored Data","volume":"9","author":"I Choi","year":"2012","journal-title":"IEEE\/ACM Transactions on Computational Biology and Bioinformatics"},{"key":"pcbi.1012444.ref038","doi-asserted-by":"crossref","unstructured":"Bouckaert RR, Frank E Evaluating the replicability of significance tests for comparing learning algorithms. Pacific-Asia conference on knowledge discovery and data mining: Springer. pp. 3\u201312.","DOI":"10.1007\/978-3-540-24775-3_3"},{"issue":"2","key":"pcbi.1012444.ref039","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/biostatistics\/kxy006","article-title":"The c-index is not proper for the evaluation of-year predicted risks","volume":"20","author":"P Blanche","year":"2019","journal-title":"Biostatistics"},{"issue":"29","key":"pcbi.1012444.ref040","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1200\/JCO.2007.13.8545","article-title":"Prediction of survival in multiple myeloma based on gene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: a study of the Intergroupe Francophone du Myelome","volume":"26","author":"O Decaux","year":"2008","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"pcbi.1012444.ref041","first-page":"2276","article-title":"A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1","volume":"109","author":"JD Shaughnessy","year":"2007","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"11","key":"pcbi.1012444.ref042","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1038\/leu.2012.127","article-title":"A gene expression signature for high-risk multiple myeloma","volume":"26","author":"R Kuiper","year":"2012","journal-title":"Leukemia"},{"issue":"1","key":"pcbi.1012444.ref043","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"WE Johnson","year":"2007","journal-title":"Biostatistics"},{"issue":"6","key":"pcbi.1012444.ref044","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The sva package for removing batch effects and other unwanted variation in high-throughput experiments","volume":"28","author":"JT Leek","year":"2012","journal-title":"Bioinformatics"},{"issue":"3","key":"pcbi.1012444.ref045","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/bjs.9736","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"102","author":"GS Collins","year":"2015","journal-title":"Journal of British Surgery"},{"issue":"12","key":"pcbi.1012444.ref046","first-page":"e5870","article-title":"Guidelines for developing and reporting machine learning predictive models in biomedical research: a multidisciplinary view","volume":"18","author":"W Luo","year":"2016","journal-title":"Journal of medical Internet research"},{"issue":"2","key":"pcbi.1012444.ref047","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/bib\/bbp059","article-title":"Dealing with missing values in large-scale studies: microarray data imputation and beyond","volume":"11","author":"T Aittokallio","year":"2010","journal-title":"Briefings in bioinformatics"},{"issue":"25","key":"pcbi.1012444.ref048","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1002\/sim.8682","article-title":"Handling missing predictor values when validating and applying a prediction model to new patients","volume":"39","author":"J Hoogland","year":"2020","journal-title":"Statistics in medicine"},{"issue":"1","key":"pcbi.1012444.ref049","first-page":"1","article-title":"Missing value imputation in high-dimensional phenomic data: imputable or not, and how","volume":"15","author":"SG Liao","year":"2014","journal-title":"BMC bioinformatics"},{"key":"pcbi.1012444.ref050","author":"T Hastie","year":"2022","journal-title":"impute: Imputation for microarray data"},{"issue":"2","key":"pcbi.1012444.ref051","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/sim.6787","article-title":"Sample size considerations for the external validation of a multivariable prognostic model: a resampling study","volume":"35","author":"GS Collins","year":"2016","journal-title":"Statistics in medicine"},{"issue":"6","key":"pcbi.1012444.ref052","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/\u03b2-catenin signaling and disease","volume":"149","author":"H Clevers","year":"2012","journal-title":"Cell"},{"issue":"1\u20132","key":"pcbi.1012444.ref053","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cytogfr.2005.09.006","article-title":"TGF-\u03b2 and cancer","volume":"17","author":"B Bierie","year":"2006","journal-title":"Cytokine & growth factor reviews"},{"issue":"4","key":"pcbi.1012444.ref054","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"DE Johnson","year":"2018","journal-title":"Nature reviews Clinical oncology"},{"issue":"4","key":"pcbi.1012444.ref055","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"V Thorsson","year":"2018","journal-title":"Immunity"},{"issue":"12","key":"pcbi.1012444.ref056","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"WH Fridman","year":"2017","journal-title":"Nature reviews Clinical oncology"},{"key":"pcbi.1012444.ref057","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00018-016-2135-z","article-title":"Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies","volume":"73","author":"C Guillerey","year":"2016","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"1","key":"pcbi.1012444.ref058","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-021-01162-7","article-title":"Prognostic and predictive biomarker developments in multiple myeloma.","volume":"14","author":"CT Wallington-Beddoe","year":"2021","journal-title":"Journal of Hematology & Oncology"},{"issue":"4","key":"pcbi.1012444.ref059","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1467-9868.2010.00740.x","article-title":"Stability selection","volume":"72","author":"N Meinshausen","year":"2010","journal-title":"Journal of the Royal Statistical Society: Series B (Statistical Methodology)"},{"issue":"4","key":"pcbi.1012444.ref060","first-page":"1484","article-title":"Stability","volume":"19","author":"B Yu","year":"2013","journal-title":"Bernoulli"},{"issue":"4","key":"pcbi.1012444.ref061","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3390\/cancers13040625","article-title":"The immune microenvironment in multiple myeloma: friend or foe","volume":"13","author":"R Lopes","year":"2021","journal-title":"Cancers"},{"issue":"24","key":"pcbi.1012444.ref062","first-page":"2731","article-title":"Cancer immunoediting and immune dysregulation in multiple myeloma","volume":"136","author":"K Nakamura","year":"2020","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"13","key":"pcbi.1012444.ref063","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.3390\/cancers13133213","article-title":"Mechanisms of immune evasion in multiple myeloma: Open questions and therapeutic opportunities","volume":"13","author":"C Botta","year":"2021","journal-title":"Cancers"},{"issue":"22","key":"pcbi.1012444.ref064","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.1158\/1078-0432.CCR-16-0868","article-title":"Immune therapies in multiple myeloma","volume":"22","author":"SK Kumar","year":"2016","journal-title":"Clinical Cancer Research"},{"issue":"5","key":"pcbi.1012444.ref065","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/apt.15132","article-title":"Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin\u2019s lymphoma and multiple myeloma","volume":"49","author":"T-H Su","year":"2019","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"2","key":"pcbi.1012444.ref066","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3109\/10428194.2011.610013","article-title":") High prevalence of hepatitis B virus infection in multiple myeloma","volume":"53","author":"B Huang","year":"2012","journal-title":"Leukemia & Lymphoma"},{"issue":"3","key":"pcbi.1012444.ref067","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/imj.12981","article-title":"Association between hepatitis B virus infection and risk of multiple myeloma: a systematic review and meta-analysis","volume":"46","author":"Y Li","year":"2016","journal-title":"Internal Medicine Journal"},{"issue":"11","key":"pcbi.1012444.ref068","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.3390\/cancers11111819","article-title":"Reactivation of hepatitis B virus in patients with multiple myeloma","volume":"11","author":"Y Tsukune","year":"2019","journal-title":"Cancers"},{"issue":"2","key":"pcbi.1012444.ref069","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/1096-8652(200102)66:2<123::AID-AJH1028>3.0.CO;2-P","article-title":"Multiple myeloma and human immunodeficiency virus-1 (HIV-1) infection","volume":"66","author":"TT Yee","year":"2001","journal-title":"American journal of hematology"},{"issue":"12","key":"pcbi.1012444.ref070","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/cgt.2009.40","article-title":"Dynamics of multiple myeloma tumor therapy with a recombinant measles virus","volume":"16","author":"D Dingli","year":"2009","journal-title":"Cancer gene therapy"},{"issue":"12","key":"pcbi.1012444.ref071","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1038\/s41375-020-0828-7","article-title":"Oncolytic measles virus therapy enhances tumor antigen-specific T-cell responses in patients with multiple myeloma","volume":"34","author":"N Packiriswamy","year":"2020","journal-title":"Leukemia"},{"key":"pcbi.1012444.ref072","first-page":"4645","article-title":"Shingles Occurs in Only 0.5% of Myeloma Patients on Any Dose of Antiviral Prophylaxis","volume":"130","author":"J Chu","year":"2017","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"11","key":"pcbi.1012444.ref073","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1080\/10428194.2017.1312369","article-title":"Risk and impact of tuberculosis in patients with multiple myeloma","volume":"58","author":"C-K Tsai","year":"2017","journal-title":"Leukemia & Lymphoma"},{"issue":"1","key":"pcbi.1012444.ref074","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5045\/br.2013.48.1.35","article-title":"Poor prognostic significance of Mycobacterium tuberculosis infection during bortezomib-containing chemotherapy in patients with multiple myeloma","volume":"48","author":"J-S Ahn","year":"2013","journal-title":"Blood research"},{"issue":"4","key":"pcbi.1012444.ref075","article-title":"Tuberculosis of spine as the first clinical presentation of Multiple Myeloma: a case report","volume":"71","author":"Z Ahmadinejad","year":"2013","journal-title":"Tehran University Medical Journal"},{"issue":"12","key":"pcbi.1012444.ref076","article-title":"Meningococcal Septic Oligoarthritis: An Unusual Presentation Revealing Concurrent Multiple Myeloma","volume":"15","author":"LA Rocha","year":"2023","journal-title":"Cureus"},{"issue":"3","key":"pcbi.1012444.ref077","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1016\/j.clml.2022.12.003","article-title":"Rates of influenza and pneumococcal vaccination and correlation with survival in multiple myeloma patients","volume":"23","author":"MA Thompson","year":"2023","journal-title":"Clinical Lymphoma Myeloma and Leukemia"},{"issue":"7","key":"pcbi.1012444.ref078","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.3324\/haematol.2014.116772","article-title":"Efficacy of single versus boost vaccination against influenza virus in patients with multiple myeloma","volume":"100","author":"M Hahn","year":"2015","journal-title":"Haematologica"},{"issue":"3","key":"pcbi.1012444.ref079","doi-asserted-by":"crossref","first-page":"c125","DOI":"10.1159\/000232592","article-title":"Drug development: from concept to marketing!","volume":"113","author":"N am Tamimi","year":"2009","journal-title":"Nephron Clinical Practice"},{"issue":"12","key":"pcbi.1012444.ref080","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nrd3025","article-title":"The future of drug development: advancing clinical trial design","volume":"8","author":"J Orloff","year":"2009","journal-title":"Nature reviews Drug discovery"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1012444","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1012444","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T17:39:27Z","timestamp":1726853967000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1012444"}},"subtitle":[],"editor":[{"given":"Gianfilippo","family":"Coppola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":80,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1012444","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pcbi.1012444","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,10]]}}}